News

Emcure Pharma stock was quoting at ₹1,382.5, up 1.5 per cent from the previous day's close of ₹1,362.5 as the company ...
The partnership enhances Emcure’s existing diabetes portfolio and reinforces its efforts to expand access to affordable, high ...
Emcure Pharmaceuticals partners with Sanofi India to distribute and promote oral anti-diabetic products in India.
Emcure Pharmaceuticals and Sanofi India have announced a distribution agreement. Emcure will promote Sanofi India's oral anti ...
Emcure Pharmaceuticals Ltd. and Sanofi India Limited today entered into an exclusive distribution and promotion agreement for ...
Emcure Pharma share price rose in trade after the company announced that United States Food and Drug Administration (USFDA) ...
Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...
KPRDO acknowledges Emcure’s positive response on exclusive stockist appointment for special category sales: Nandita ...
Pune: Emcure Pharmaceuticals Limited has announced the incorporation of a new wholly-owned subsidiary named Emcure Wellness Private Limited. The new entity was officially incorporated on July ...
Pune: Emcure Pharma has announced the appointment of R.S. Vasan as President - India Business and Senior Management Personnel ...
Emcure Pharma IPO price band The IPO is priced in the range of Rs 960-1008 per share, where investors can bid for 14 shares in one lot. At the upper end, the company plans to raise Rs 1952 crore ...
Generic drugmaker Emcure Pharmaceuticals convinced a federal court in Seattle, Washington, on Monday to throw out a lawsuit that accused it of stealing trade secrets from biopharma company HDT Bio ...